289 COPERNICUS: A Multinational Pragmatic Phase 2 Trial of Subcutaneous (SC) Amivantamab (Ami) in Common EGFR-Mutated (cEGFRm) NSCLC

Lung Cancer 2026

View at publisher
Authors: Anna Minchom, Balázs Halmos, Narjust Florez, Sarah B. Goldberg, Wade Thomas Iams, Xiuning Le, Ticiana Leal, Luis Estuardo Raez, Jonathan Wesley Riess, Danny Nguyen, Joshua K. Sabari, David Bjork
+7 more Nichelle Stigger, Yichuan Xia, Paul Cifuentes, Farah Shanoon, James Penton, Agnes Hultén, Melissa Johnson
DOI: 10.1016/j.lungcan.2026.109237
Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Lung Cancer Diagnosis and Treatment

Publication details

Journal / source
Lung Cancer
Volume
212
Pages
109237–109237
Publication date
1 February 2026
Language
EN